Activation of hepatocyte growth factor by urokinase-type plasminogen activator is ionic strength-dependent

被引:11
|
作者
Mars, WM
Jo, M
Gonias, SL
机构
[1] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA
[2] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA
关键词
epsilon-amino-caproic acid (EACA); hepatocyte growth factor (HGF); HGF receptor (MET); ionic strength; urokinase-type plasminogen activator (u-PA); u-PA receptor (u-PAR);
D O I
10.1042/BJ20042028
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The hepatocyte growth factor (HGF) is a multifunctional cytokine that is produced as latent scHGF (single chain HGF). Various proteases reportedly cleave scHGF to generate the active two-chain form (HGF), including u-PA (urokinase-type plasminogen activator), t-PA (tissue-type plasminogen activator), kallikrein, Factor XIa, Factor XIIa, HGF activator and matriptase. Considerable evidence indicates that, in vivo, u-PA activates scHGF in the liver; however, the in vivo results have not been uniformly supported by in vitro experiments. We now report that cleavage of scHGF by high-molecular-mass u-PA (abbreviated u-PA throughout) is sensitive to ionic strength. scHGF cleavage by u-PA was accelerated as the ionic strength was decreased. This result was equivalent irrespective of whether the predominant anion was chloride or acetate. Lmw-u-PA (low-molecular-mass u-PA) was ineffective at cleaving scHGF, regardless of ionic strength. Although scHGF shares homology with plasminogen, EACA (epsilon-amino-caproic acid) did not regulate u-PA-mediated scHGF cleavage. Soluble HGF receptor (MET) and soluble u-PAR (u-PA receptor) inhibited the scHGF cleavage. These results support a model in which the ability of u-PA to activate scHGF in vivo may be highly dependent on local conditions within the extracellular space.
引用
收藏
页码:311 / 315
页数:5
相关论文
共 50 条
  • [31] CONTACT ACTIVATION AND SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR
    DOOIJEWAARD, G
    BINNEMA, DJ
    KLUFT, C
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 47 - 47
  • [32] Simultaneous up-regulation of urokinase-type plasminogen activator (uPA) and uPA receptor by hepatocyte growth factor/scatter factor in human glioma cells
    Takuzou Moriyama
    Hiroaki Kataoka
    Ryouichi Hamasuna
    Etsuo Yoshida
    Tetsuro Sameshima
    Tsutomu Iseda
    Kiyotaka Yokogami
    Shinichi Nakano
    Masashi Koono
    Shinichiro Wakisaka
    Clinical & Experimental Metastasis, 1999, 17 : 873 - 879
  • [33] Thrombin stimulation of platelets induces plasminogen activation mediated by endogenous urokinase-type plasminogen activator
    Lenich, C
    Liu, JN
    Gurewich, V
    BLOOD, 1997, 90 (09) : 3579 - 3586
  • [34] Simultaneous up-regulation of urokinase-type plasminogen activator (uPA) and uPA receptor by hepatocyte growth factor/scatter factor in human glioma cells
    Moriyama, T
    Kataoka, H
    Hamasuna, R
    Yoshida, E
    Sameshima, T
    Iseda, T
    Yokogami, K
    Nakano, S
    Koono, M
    Wakisaka, S
    CLINICAL & EXPERIMENTAL METASTASIS, 1999, 17 (10) : 873 - 879
  • [35] Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 as a prognostic factor in human colorectal carcinomas
    Fujii, T
    Obara, T
    Tanno, S
    Ura, H
    Kohgo, Y
    HEPATO-GASTROENTEROLOGY, 1999, 46 (28) : 2299 - 2308
  • [36] Urokinase-type plasminogen activator receptor: A beacon of malignancy?
    Drapkin, Ronny
    Clauss, Adam
    Skates, Steven
    CLINICAL CANCER RESEARCH, 2008, 14 (18) : 5643 - 5645
  • [37] Small molecule inhibitors of urokinase-type plasminogen activator
    Rockway, TW
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2003, 13 (06) : 773 - 786
  • [38] Structure, function and antagonists of urokinase-type plasminogen activator
    Carriero, Maria Vincenza
    Franco, Paola
    Vocca, Imma
    Alfano, Daniela
    Votta, Giuseppina
    Longanesi-Cattani, Immacolata
    Bifulco, Katia
    Mancini, Alessandro
    Caputi, Mario
    Stoppelli, Maria Patrizia
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2009, 14 : 3782 - 3794
  • [39] Urokinase-type plasminogen activator receptor in IgA nephropathy
    Ahn, Shin-Young
    Chin, Ho Jun
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2014, 29 (02): : 166 - 169
  • [40] Identification of a novel inhibitor of urokinase-type plasminogen activator
    Zhu, Ming
    Gokhale, Vijay M.
    Szabo, Lajos
    Munoz, Ruben M.
    Baek, Hyounggee
    Bashyam, Sridevi
    Hurley, Laurence H.
    Von Hoff, Daniel D.
    Han, Haiyong
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (04) : 1348 - 1356